These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10785585)

  • 1. Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group.
    de Haes J; Curran D; Young T; Bottomley A; Flechtner H; Aaronson N; Blazeby J; Bjordal K; Brandberg Y; Greimel E; Maher J; Sprangers M; Cull A
    Eur J Cancer; 2000 May; 36(7):821-5. PubMed ID: 10785585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
    Kavadas V; Blazeby JM; Conroy T; Sezer O; Holzner B; Koller M; Buckels J;
    Eur J Cancer; 2003 Jun; 39(9):1259-63. PubMed ID: 12763214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The quality of life in head and neck cancer patients: description of randomized examination formula based on standardized questionnaires EORTC QLQ C-30, EORTC QTQ-H-N35 and Kiel Questionnaire].
    Wierzbicka M; Kuśnierkiewicz M; Wójtowicz JG; Maune S; Szyfter W
    Otolaryngol Pol; 2001; 55(3):287-92. PubMed ID: 11765444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.
    Koller M; Warncke S; Hjermstad MJ; Arraras J; Pompili C; Harle A; Johnson CD; Chie WC; Schulz C; Zeman F; van Meerbeeck JP; Kuliś D; Bottomley A; ;
    Cancer; 2015 Dec; 121(24):4300-23. PubMed ID: 26451520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
    Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
    Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life assessment in daily clinical oncology practice: a feasibility study.
    Detmar SB; Aaronson NK
    Eur J Cancer; 1998 Jul; 34(8):1181-6. PubMed ID: 9849476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus).
    Carlson LE; Bultz BD; Morris DG
    Health Qual Life Outcomes; 2005 Jan; 3():7. PubMed ID: 15676074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy.
    Coates A; Porzsolt F; Osoba D
    Eur J Cancer; 1997 Jun; 33(7):1025-30. PubMed ID: 9376182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection.
    Van Steen K; Curran D; Kramer J; Molenberghs G; Van Vreckem A; Bottomley A; Sylvester R
    Stat Med; 2002 Dec; 21(24):3865-84. PubMed ID: 12483772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utility of the questionnaire for quality of life EORTC-QLQ-C30 in psycho-oncological outcome research].
    Determann MM; Kollenbaum VE; Henne-Bruns D
    Zentralbl Chir; 2004 Jan; 129(1):14-7. PubMed ID: 15011106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients evaluate a quality of life scale: whose life is it anyway?
    Speca M; Robinson JW; Goodey E; Frizzell B
    Cancer Pract; 1994; 2(5):365-70. PubMed ID: 7697075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach.
    Koller M; Aaronson NK; Blazeby J; Bottomley A; Dewolf L; Fayers P; Johnson C; Ramage J; Scott N; West K;
    Eur J Cancer; 2007 Aug; 43(12):1810-20. PubMed ID: 17689070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of instruments for measuring quality of life in patients with lung cancer.
    Hollen PJ; Gralla RJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):31-40. PubMed ID: 8610235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records.
    Velikova G; Wright P; Smith AB; Stark D; Perren T; Brown J; Selby P
    J Clin Oncol; 2001 Apr; 19(7):2064-73. PubMed ID: 11283140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report.
    Cull A; Howat S; Greimel E; Waldenstrom AC; Arraras J; Kudelka A; Chauvenet L; Gould A; ;
    Eur J Cancer; 2001 Jan; 37(1):47-53. PubMed ID: 11165129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life assessment in chemotherapy trials for non-small cell lung cancer: are theory and practice significantly different?
    Hopwood P
    Semin Oncol; 1996 Oct; 23(5 Suppl 10):60-4. PubMed ID: 8893884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-specific quality of life questionnaires: the state of the art in Europe.
    Cull AM
    Eur J Cancer; 1997 Jul; 33 Suppl 6():S3-7. PubMed ID: 9404233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
    Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
    Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disregarding clinical trial-based patient-reported outcomes is unwarranted: Five advances to substantiate the scientific stringency of quality-of-life measurement.
    Sprangers MA
    Acta Oncol; 2010; 49(2):155-63. PubMed ID: 20059312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.